LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,779,982
تعداد دریافت فایل اصل مقاله8,803,891
Koopaei, Soheila, Fathi Kazerooni, Anahita, Ghafoori, Mahyar, Alviri, Mohammadreza, Pashaei, Fakhereh, Saligheh Rad, Hamidreza. (1402). Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate. سامانه مدیریت نشریات علمی, 13(3), 251-260. doi: 10.31661/jbpe.v0i0.2008-1158
Soheila Koopaei; Anahita Fathi Kazerooni; Mahyar Ghafoori; Mohammadreza Alviri; Fakhereh Pashaei; Hamidreza Saligheh Rad. "Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate". سامانه مدیریت نشریات علمی, 13, 3, 1402, 251-260. doi: 10.31661/jbpe.v0i0.2008-1158
Koopaei, Soheila, Fathi Kazerooni, Anahita, Ghafoori, Mahyar, Alviri, Mohammadreza, Pashaei, Fakhereh, Saligheh Rad, Hamidreza. (1402). 'Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate', سامانه مدیریت نشریات علمی, 13(3), pp. 251-260. doi: 10.31661/jbpe.v0i0.2008-1158
Koopaei, Soheila, Fathi Kazerooni, Anahita, Ghafoori, Mahyar, Alviri, Mohammadreza, Pashaei, Fakhereh, Saligheh Rad, Hamidreza. Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate. سامانه مدیریت نشریات علمی, 1402; 13(3): 251-260. doi: 10.31661/jbpe.v0i0.2008-1158

Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate

Journal of Biomedical Physics and Engineering
دوره 13، شماره 3، مرداد و شهریور 2023، صفحه 251-260    اصل مقاله (1021.17 K)
نوع مقاله: Original Research
شناسه دیجیتال (DOI): 10.31661/jbpe.v0i0.2008-1158
نویسندگان
Soheila Koopaei1، 2؛ Anahita Fathi Kazerooni2؛ Mahyar Ghafoori3؛ Mohammadreza Alviri2؛ Fakhereh Pashaei1، 4؛ Hamidreza Saligheh Rad* 1، 2
1Quantitative MR Imaging and Spectroscopy Group, Research Center for Molecular and Cellular Imaging, Institute for Advanced Medical Technologies, Imam Hospital, Tehran, Iran
2Department of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Science Tehran, Iran
3Department of Radiology, Hazrat Rasoul Akram University Hospital, Tehran, Iran
4Radiation Sciences Research Center (RSRC), Aja University of Medical Sciences, Tehran, Iran
چکیده
Background: The most common cancer (non-cutaneous) malignancy among men is prostate cancer. Management of prostate cancer, including staging and treatment, playing an important role in decreasing mortality rates. Among all current diagnostic tools, multiparametric MRI (mp-MRI) has shown high potential in localizing and staging prostate cancer. Quantification of mp-MRI helps to decrease the dependency of diagnosis on readers’ opinions.
Objective: The aim of this research is to set a method based on quantification of mp-MRI images for discrimination between benign and malignant prostatic lesions with fusion-guided MR imaging/transrectal ultrasonography biopsy as a pathology validation reference.
Material and Methods: It is an analytical research that 27 patients underwent the mp-MRI examination, including T1- and T2- weighted and diffusion weighted imaging (DWI). Quantification was done by calculating radiomic features from mp-MRI images. Receiver-operating-characteristic curve was done for each feature to evaluate the discriminatory capacity and linear discriminant analysis (LDA) and leave-one-out cross-validation for feature filtering to estimate the sensitivity, specificity and accuracy of the benign and malignant lesion differentiation process is used.
Results: An accuracy, sensitivity and specificity of 92.6%, 95.2% and 83.3%, respectively, were achieved from a subset of radiomics features obtained from T2-weighted images and apparent diffusion coefficient (ADC) maps for distinguishing benign and malignant prostate lesions. 
Conclusion: Quantification of mp-MRI (T2-weighted images and ADC-maps) based on radiomics feature has potential to distinguish benign with appropriate accuracy from malignant prostate lesions. This technique is helpful in preventing needless biopsies in patients and provides an assisted diagnosis for classifications of prostate lesions.
کلیدواژه‌ها
Prostatic Neoplasms؛ Multiparametric Magnetic Resonance Imaging؛ Radiomics Fatures؛ Quantification Analysis
سایر فایل های مرتبط با مقاله
مراجع
  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. doi: 10.1002/ijc.25516. PubMed PMID: 21351269.
  2. Verma S, Rajesh A. A clinically relevant approach to imaging prostate cancer. AJR Am J Roentgenol. 2011;196(3_supplement):S1-10. doi: 10.2214/AJR.09.7196. PubMed PMID: 21343529.
  3. Schröder FH. Screening for prostate cancer: current status of ERSPC and screening-related issues. Recent Results Cancer. 2014;202:47-51. doi: 10.1007/978-3-642-45195-9_5. PubMed PMID: 24531776.
  4. Thompson IM, Ankerst DP, Chi C, Lucia MS, et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA. 2005;294(1):66-70. doi: 10.1001/jama.294.1.66. PubMed PMID: 15998892.
  5. Gretzer MB, Partin AW. PSA markers in prostate cancer detection. Urologic Clinics of North America. 2003;30(4):677-86. doi: 10.1016/s0094-0143(03)00057-0. PubMed PMID: 14680307.
  6. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52-62. doi: 10.3322/caac.21203. PubMed PMID: 24114568.
  7. Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol. 2012;61(5):1019-24. doi: 10.1016/j.eururo.2012.01.050. PubMed PMID: 22336380. PubMed PMCID: PMC4659370.
  8. Pokorny MR, De Rooij M, Duncan E, Schröder FH. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound–guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol. 2014;66(1):22-9. doi: 10.1016/j.eururo.2014.03.002. PubMed PMID: 24666839.
  9. Phillips R. Stem cells repopulate tumours. Nat Rev Urol. 2015;12(2):63. doi: 10.1038/nrurol.2014.352. PubMed PMID: 25535001.
  10. Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol. 2013;189(6):2039-46. doi: 10.1016/j.juro.2013.02.072. PubMed PMID: 23485507. PubMed PMCID: PMC3925148.
  11. Sanders A, Buchan N. Infection-related hospital admissions after transrectal biopsy of the prostate. ANZ J Surg. 2013;83(4):246-8. doi: 10.1111/ans.12073. PubMed PMID: 23346881.
  12. Utrera NM, Alvarez MB, Polo JM, et al. Infectious complications after transrectal ultrasound-guided prostatic biopsy. Analysis of our experience. Arch Esp Urol. 2011;64(7):605-10. PubMed PMID: 21965258.
  13. Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011;261(1):46-66. doi: 10.1148/radiol.11091822. PubMed PMID: 21931141.
  14. Panebianco V, Barchetti F, Sciarra A, Ciardi A, et al. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol. 2015;33(1):e1-17. doi: 10.1016/j.urolonc.2014.09.013. PubMed PMID: 25443268.
  15. Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging–reporting and data system: 2015, version 2. Eur Urol. 2016;69(1):16-40. doi: 10.1016/j.eururo.2015.08.052. PubMed PMID: 26427566. PubMed PMCID: PMC6467207.
  16. Desouza NM, Reinsberg SA, Scurr ED, Brewster JM, Payne GS. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol. 2007;80(950):90-5. doi: 10.1259/bjr/24232319. PubMed PMID: 17303616.
  17. Elbuluk O, Turkbey B, Choyke P. Prostate Imaging, InInterventional Urology. Springer International Publishin; 2016. p. 59-72.
  18. Haider MA, Van Der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol. 2007;189(2):323-8. doi: 10.2214/AJR.07.2211. PubMed PMID: 17646457.
  19. Fathi Kazerooni A, Nabil M, Haghighat Khah H, Alviri M, et al ADC-derived spatial features can accurately classify adnexal lesions. J Magn Reson Imaging. 2018;47(4):1061-71. doi: 10.1002/jmri.25854. PubMed PMID: 28901638.
  20. You MW, Kim MH, Kim JK, Cho KS. The characteristics and spatial distributions of initially missed and rebiopsy-detected prostate cancers. 2016;35(3):226. doi: 10.14366/usg.15065. PubMed PMID: 27048261. PubMed PMCID: PMC4939716.
  21. Abdi H, Zargar H, Goldenberg SL, Walshe T, et al. Multiparametric magnetic resonance imaging–targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results. Urol Oncol. 2015;33(4):165.e1-7. doi: 10.1016/j.urolonc.2015.01.004. PubMed PMID: 25665509.
  22. Javali TD, Dwivedi DK, Kumar R, Jagannathan NR, et al. Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination. Int J Urol. 2014;21(3):257-62. doi: 10.1111/iju.12258. PubMed PMID: 23980749.
  23. Bae H, Yoshida S, Matsuoka Y, Nakajima H, et al. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2014;46(3):555-61. doi: 10.1007/s11255-013-0557-1. PubMed PMID: 24022845.
  24. Fusco R, Sansone M, Petrillo M, Setola SV, et al. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging. Magnetic Resonance Imaging. 2016;34(7):839-45. doi: 10.1016/j.mri.2016.04.001. PubMed PMID: 27071309.
  25. Hoang Dinh A, Melodelima C, Souchon R, et al. Quantitative analysis of prostate multiparametric MR images for detection of aggressive prostate cancer in the peripheral zone: a multiple imager study. 2016;280(1):117-27. doi: 10.1148/radiol.2016151406. PubMed PMID: 26859255.
  26. Hauth E, Halbritter D, Jaeger H, Hohmuth H, Beer M. Diagnostic value of semi-quantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate. TBr J Radiol. 2017;90(1078):20170067. doi: 10.1259/bjr.20170067. PubMed PMID: 28749167.
  27. Khalvati F, Wong A, Haider MA. Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models. BMC Med Imaging. 2015;15(1):27. doi: 10.1186/s12880-015-0069-9. PubMed PMID: 26242589. PubMed PMCID: PMC4524105.
آمار
تعداد مشاهده مقاله: 20,208
تعداد دریافت فایل اصل مقاله: 400


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب